| Chemoprevention of
Cancer | |
|
Aspirin, Inflammation Markers and Colorectal
Adenoma | John A. Baron/
Albert Einstein Medical School |
| Chemoprevention of Arsenic-Induced Skin
Cancer |
John A. Baron /
Univ. of
Chicago |
| Colorectal Chemoprevention
with Calcium and Vitamin D | John A.
Baron |
| Combined Analysis of
Aspirin and Colorectal Chemoprevention
Trials | John A. Baron |
|
Diet, DNA Methylation and Other Epigenetic
Events & Cancer
Prevention | John A. Baron/Univ.
of Texas |
|
Folate, Vitamin D and Calcium in Colorectal
Cancer | John A. Baron /
Univ. of Southern California |
|
Folate, 1-Carbon Nutrients, Gene Variants
& Colon Cancer | John A.
Baron/
Harvard University
|
Cancer Epidemiology |
| GI Cancers |
| Advanced Colorectal
Neoplasia Following Polypectomy |
John A. Baron /Univ. of
Arizona |
| Cyclin D1- A
Chemoprevention Effect Marker in the
Colon | Angeline Andrew |
|
DNA Repair Gene Polymorphisms and Pancreatic
Cancer | Eric Duell |
|
Molecular Epidemiology of Pancreatic Cancer
| Eric Duell/
Univ. of
California San Francisco |
|
TGF-Beta Pathway Polymorphisms in Familial
Colorectal Cancer | John A.
Baron/
Northwestern Univ. |
| Lung
Cancer |
|
Environmental Epidemiology of Lung Cancers in NH: A
Multilevel Approach Using GIS and Case Control
| Eric Duell |
| Somatic
Alterations in Lung Tumors | Angeline
Andrew |
| Skin
Cancers |
| Atypical Nevi in
Melanoma: A Case Control Study | Linda
Titus-Ernstoff |
| Epidemiology of
Non-Melanoma Skin Cancer in New Hampshire | Margaret
Karagas |
| Etiologic Role of
HPV in Keratinocyte Cancers | Margaret
Karagas |
| Melanoma
Pathogenesis | Linda Titus-Ernstoff |
| Molecular
Epidemiology of Non-Melanoma Skin Cancer | Margaret
Karagas/
Univ. of Minnesota |
| Women's Melanoma
Risk | Margaret Karagas |
| Breast, Ovarian and Endometrial Cancer
|
| Breast Cancer Detection
Using Electrical Tomography Data | Eugene
Demidenko |
| Hormones, Lifestyle
and Breast Cancer | Linda Titus-Ernstoff |
| International
Breast Cancer Study Group | Bernard Cole |
| Genes, Hormones
and Environment in an Ovarian Cancer Model | Linda
Titus-Ernstoff /
Brigham & Women’s
Hospital |
| Ovarian Cancer Risk
and Hypogonadotropic Hypogonadism | Linda
Titus-Ernstoff /
Brigham & Women’s
Hospital |
| Ovarian Cancer
Specialized Program of Research Excellence
(SPORE) | Linda Titus-Ernstoff /
Brigham &
Women’s Hospital |
| Risk Factors and
Biomarkers for In Situ Breast Cancer | Linda
Titus-Ernstoff |
| GU Cancer |
| Arsenic
Epidemiology, Biomarkers and Exposure
Assessment | Margaret Karagas |
| Bladder Cancer
Prognostic Indicators | Angeline Andrew |
| Comprehensive
Assessment of Bladder Cancer Genetic
Susceptibility | Angeline Andrew |
| Molecular
Epidemiology of Bladder Cancer | Margaret
Karagas/
Harvard Univ. |
| Women's and Children's
Health |
| Antioxidant Status,
Diet and Early Pregnancy | Marlene Goldman |
| Follow-Up DES-Exposed
Cohorts | Linda Titus-Ernstoff |
| Risk and
Recovery in Complex Environments: L&D as a Model
| Marlene Goldman |
| Biostatistics and
Bioinformatics |
| Bioinformatics
Strategies for Biodefense Vaccine Research | Jason
Moore |
| Genetic Architecture
of Plasma t-PA&PAI-1 | Jason Moore |
| Genetic Basis of
Trauma Recovery | Jason Moore |
| Machine Learning
Prediction of Cancer Susceptibility | Jason
Moore |
| Measurement Errors in
Cancer Epidemiology | Tor D. Tosteson |
| Other Studies |
| Research Cores and Shares
Resources |
| Other
Collaborative Research |
